Encephalitis Associated With SARS-CoV-2 Infection in a Child With Chiari Malformation Type I

Abstract Background/Aim: There is increasing evidence that patients infected with SARS-CoV-2 develop neurological manifestations such as encephalitis. The purpose of this article was to present a case of viral encephalitis associated with SARS-CoV-2 in a 14-year-old child with Chiari malformation type I. Case Report: The patient manifested frontal headache, nausea, vomiting, skin pallor, right side Babinski sign and was diagnosed with Chiari malformation type I. He was admitted with generalized seizures and suspected encephalitis. Brain inflammation and viral RNA in the cerebrospinal fluid suggested SARS-CoV-2 encephalitis. These findings indicate that the SARS-CoV-2 test in CSF of patients with neurological manifestations, confusion, and fever during the COVID-19 pandemic should be carried out even when there is no evidence of respiratory infection. To our knowledge, this presentation of encephalitis associated with COVID-19 has not yet been reported in a patient with a congenital syndrome such as Chiari malformation type I. Conclusion: Further clinical data are needed to determine the complications of encephalitis due to SARS-CoV-2 in patients with Chiari malformation type I to standardize diagnosis and treatment.

[1]  R. D. del Ángel,et al.  Cholesterol-Rich Lipid Rafts as Platforms for SARS-CoV-2 Entry , 2021, Frontiers in Immunology.

[2]  S. Saffari,et al.  Encephalitis as a neurological complication of COVID‐19: A systematic review and meta‐analysis of incidence, outcomes, and predictors , 2021, European journal of neurology.

[3]  T. Kusaka,et al.  Neonatal Jaundice in Preterm Infants with Bilirubin Encephalopathy , 2021, Neonatology.

[4]  Jiajia Zhu,et al.  Associations of Serum Liver Function Markers With Brain Structure, Function, and Perfusion in Healthy Young Adults , 2021, Frontiers in Neurology.

[5]  Karen C. Dannemiller,et al.  Indoor Dust as a Matrix for Surveillance of COVID-19 , 2021, mSystems.

[6]  S. Mahmoudi,et al.  COVID-19 and congenital heart disease: a case series of nine children , 2021, World Journal of Pediatrics.

[7]  P. Grant,et al.  Neuroimaging manifestations in children with SARS-CoV-2 infection: a multinational, multicentre collaborative study , 2020, The Lancet Child & Adolescent Health.

[8]  Joseph R. Keen,et al.  COVID-19 Associated Encephalopathies and Cerebrovascular Disease: The New Orleans Experience , 2020, Neurosurgery.

[9]  R. Kuzniecky,et al.  Central nervous system complications associated with SARS-CoV-2 infection: integrative concepts of pathophysiology and case reports , 2020, Journal of Neuroinflammation.

[10]  P. Matthews,et al.  Neurological and neuropsychiatric complications of COVID-19 in 153 patients: a UK-wide surveillance study , 2020, The Lancet Psychiatry.

[11]  A. Dumont,et al.  Coronavirus 2019 (COVID-19)–Associated Encephalopathies and Cerebrovascular Disease: The New Orleans Experience , 2020, World Neurosurgery.

[12]  Li Yang,et al.  Lymphopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A systemic review and meta-analysis , 2020, International Journal of Infectious Diseases.

[13]  J. Sejvar,et al.  Neurological associations of COVID-19 , 2020, The Lancet Neurology.

[14]  N. Enomoto,et al.  A first case of meningitis/encephalitis associated with SARS-Coronavirus-2 , 2020, International Journal of Infectious Diseases.

[15]  Y. Hu,et al.  Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China , 2020, The Lancet.

[16]  Yao Xiao,et al.  TORCH screening used appropriately in China?─three years results from a teaching hospital in northwest China , 2019, BMC Pregnancy and Childbirth.

[17]  Ying Dong,et al.  Seasonal influence on TORCH infection and analysis of multi‐positive samples with indirect immunofluorescence assay , 2019, Journal of clinical laboratory analysis.

[18]  B. Martin,et al.  Morphometric and volumetric comparison of 102 children with symptomatic and asymptomatic Chiari malformation Type I. , 2018, Journal of neurosurgery. Pediatrics.

[19]  Q. Zhong,et al.  Evaluation of a Novel Array-Based Toxoplasma, Rubella, Cytomegalovirus, and Herpes Simplex Virus IgG Enzyme Linked Immunosorbent Assay and Its Comparison with Virion/Serion Enzyme Linked Immunosorbent Assays , 2013, Annals of Laboratory Medicine.

[20]  Rakesh K. Gupta,et al.  Imaging of central nervous system viral diseases , 2012, Journal of magnetic resonance imaging : JMRI.

[21]  A. Isla Guerrero,et al.  Malformations of the craniocervical junction (chiari type I and syringomyelia: classification, diagnosis and treatment) , 2009, BMC musculoskeletal disorders.

[22]  E. Solomou,et al.  Co-existence of Chiari malformation type I and Epstein–Barr virus meningoencephalitis in a 3-year-old child: case report and review of the literature , 2005, Neuroradiology.